Synergistic combinations of OX40L antibodies for the treatment of GvHD
US9868789B2 · kind B2 · utility
6Cited by
18References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2017 |
| Grant date | Jan 16, 2018 |
| Priority date | — |
| Expiry date | May 24, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.